| Modeling risk for lung cancer using trans-ancestry polygenic risk score, blood biomarkers, and lifestyle behaviors |
Meng Zhu |
Nanjing Medical University |
PLCO |
Jan 7, 2022 |
PLCO-892 |
| Models to study disease progression in Lung cancer patient |
YOGANAND BALAGURUNATHAN |
H. Lee Moffitt Cancer Center and Research Institute, Inc. |
PLCO |
Mar 8, 2018 |
PLCO-352 |
| Models to study disease progression in Prostate cancer patients |
Travis Gerke |
H. Lee Moffitt Cancer Center and Research Institute, Inc. |
PLCO |
Mar 23, 2018 |
PLCO-358 |
| Modern Statistical Models and Artificial Intelligence for Early Detection of Disease with Longitudinal Biomarker |
Tim Tobias Arndt |
Universität Augsburg |
PLCO |
Nov 15, 2021 |
PLCO-857 |
| Modifiable risk factors for benign prostatic hyperplasia |
Siobhan Sutcliffe |
Washington University |
PLCO |
Nov 4, 2009 |
2009-0167 |
| Modification of Ovarian, Endometrial, Colorectal, and Breast Cancer risks associated with Oral Contraceptive use |
Kara Michels |
Division of Cancer Epidemiology and Genetics, National Cancer Institute |
PLCO |
Oct 28, 2016 |
PLCO-238 |
| Modification of the Associations Between Aspirin Use and Colorectal, Ovarian, Endometrial, Breast, and Prostate Cancer Risk |
Lauren Hurwitz |
National Cancer Institute |
PLCO |
Oct 4, 2018 |
PLCO-403 |
| Modification role of tea in the association of dietary meat/fat intake with obesity and cancer risk |
Sijia Cai |
Tsinghua University |
PLCO |
Jul 8, 2024 |
PLCO-1604 |
| Modified Lung-RADS classification incorporating nodule risk calculator. |
Alain Tremblay |
THE GOVERNORS OF THE UNIVERSITY OF CALGARY |
NLST |
Nov 5, 2021 |
NLST-849 |
| Modifying Effects of Variant Oxidative Stress Related Genes in Relation to Prostate Cancer Outcomes |
LaCreis Kidd |
University of Louisville |
PLCO |
Jan 21, 2010 |
2009-0244 |
| Modular approach to comprehensive oncological decision support |
Daniel Schneider |
Innovation Center Computer Assisted Surgery, Leipzig University |
PLCO |
Jul 22, 2021 |
PLCO-813 |
| Molecular characterization of bladder tumors and studies of etiologic heterogeneity in the PLCO Trial |
Stella Koutros |
National Cancer Institute |
PLCO |
Mar 14, 2017 |
2016-0045 |
| Molecular characterization of breast tumors in relation to risk factors and survival |
Montserrat Garcia-Closas |
National Cancer Institute |
PLCO |
Sep 22, 2016 |
2016-0017 |
| Molecular characterization of ovarian cancers in PLCO: Evaluating subgroups and prognostic signatures |
Nicolas Wentzensen |
NCI |
PLCO |
Jun 12, 2018 |
2016-0020 |
| Molecular pathological epidemiology of colorectal cancer |
Ulrike Peters |
Fred Hutchinson Cancer Center |
PLCO |
Jul 22, 2014 |
PLCO-98 |
| Molecular Risk Stratification for Colonoscopic Surveillance |
ANDREW T. Chan |
MASSACHUSETTS GENERAL HOSPITAL |
PLCO |
|
2015-0101 |
| Monitoring with Repeatedly Measured Markers: Application to longitudinal PSA measurements in PLCO |
Paramita Saha-Chaudhuri |
McGill University |
PLCO |
Oct 12, 2018 |
PLCO-408 |
| Mortality and Morbidity Following Prostate Biopsy |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Jan 17, 2013 |
PLCO-12 |
| Mortality benefit from lung cancer screening |
Deepthi Mani |
University of Washington |
NLST |
Jul 19, 2016 |
NLST-230 |
| Mortality prediction using a combination of quantitive CT image measures |
Anton Schreuder |
Radboudumc |
NLST |
Sep 5, 2018 |
NLST-437 |
